138 related articles for article (PubMed ID: 8042613)
21. Hemoglobin S/hemoglobin Osler: a case with 3 beta globin chains. DNA sequence (AAT) proves that Hb Osler is beta 145 Tyr-->Asn.
Hutt PJ; Donaldson MH; Khatri J; Fairbanks VF; Hoyer JD; Thibodeau SN; Moxness MS; McMorrow LE; Green MM; Jones RT
Am J Hematol; 1996 Aug; 52(4):305-9. PubMed ID: 8701949
[TBL] [Abstract][Full Text] [Related]
22. Hb Hope [beta136(H14)Gly-->Asp (GGT-->GAT)]: interactions with Hb S [beta6(A3)Glu-->Val (GAG-->GTG)], other variant hemoglobins and thalassemia.
Ingle J; Adewoye A; Dewan R; Okoli M; Rollins L; Eung SH; Luo HY; Chui DH; Steinberg MH
Hemoglobin; 2004; 28(4):277-85. PubMed ID: 15658184
[TBL] [Abstract][Full Text] [Related]
23. Hb Graz or alpha 2 beta 2(2)(NA2)His-->Leu; a new beta chain variant observed in four families from southern Austria.
Liu JS; Molchanova TP; Gu LH; Wilson JB; Hopmeier P; Schnedl W; Balaun E; Krejs GJ; Huisman TH
Hemoglobin; 1992; 16(6):493-501. PubMed ID: 1487420
[TBL] [Abstract][Full Text] [Related]
24. A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.
Kutlar F; Redding-Lallinger R; Meiler SE; Bakanay SM; Borders L; Kutlar A
Acta Haematol; 2010; 124(2):120-4. PubMed ID: 20861612
[TBL] [Abstract][Full Text] [Related]
25. Compound heterozygosity for Hb S and Hb G-Copenhagen.
Carcao MD; Chang L; Poon A; Olivieri NF; Waye JS; Eng B; Patterson M; Chui DH
Hemoglobin; 1999 Nov; 23(4):379-81. PubMed ID: 10569728
[No Abstract] [Full Text] [Related]
26. Molecular exclusion of haemoglobin SD disease by prenatal diagnosis.
Fodor FH; Eng CM
Prenat Diagn; 1999 Jan; 19(1):58-60. PubMed ID: 10073909
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of clinical phenotype and genotype of unstable Hemoglobin Rush].
Ge S; Yang B; Yi W; Huang K; Liu H; Huang X; Chu J; Yang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):15-20. PubMed ID: 28186586
[TBL] [Abstract][Full Text] [Related]
28. Hb Bibba or alpha 2 136(H19)Leu-->Pro beta 2 in a Caucasian family from Alabama.
Prchal JT; Adler B; Wilson JB; Baysal E; Qin WB; Molchanova TP; Pobedimskaya DD; Kazanetz EG; Huisman TH
Hemoglobin; 1995; 19(3-4):151-64. PubMed ID: 7558871
[TBL] [Abstract][Full Text] [Related]
29. Asymptomatic child heterozygous for hemoglobin S and hemoglobin Pôrto Alegre.
Lojo L; Santiago-Borrero P; Rivera E; Renta J; Cadilla CL
Pediatr Blood Cancer; 2011 Mar; 56(3):458-9. PubMed ID: 21225927
[TBL] [Abstract][Full Text] [Related]
30. Further characterisation of Hb Okazaki [b93 (F8) Cys-Arg], a rare hemoglobin variant found in a family from Naples, Italy.
Grimaldi E; Esposito P; De Caterina M; Ferranti P
Haematologica; 2004 Aug; 89(8):ECR24. PubMed ID: 15339693
[No Abstract] [Full Text] [Related]
31. Hemoglobin Shuangfeng (alpha 27 (B8) Glu substituting for Lys): a new unstable hemoglobin variant.
Chihchuan L; Hainan T; Hweiyuen L; Shangzhi H; Ruiyou L; Bauseng W
Hemoglobin; 1981; 5(7-8):691-700. PubMed ID: 7338471
[TBL] [Abstract][Full Text] [Related]
32. Hb Lepore (Pylos)/Hb S compounds heterozygosity in two Greek families.
Voskaridou E; Konstantopoulos K; Kollia P; Papadakis M; Loukopoulos D
Am J Hematol; 1995 Jun; 49(2):131-4. PubMed ID: 7771464
[TBL] [Abstract][Full Text] [Related]
33. Interaction of hemoglobin Siriraj with hemoglobin S: a mild sickle cell syndrome.
Rhoda MD; Arous N; Garel MC; Mazarin M; Monplaisir N; Braconnier F; Rosa J; Cohen-Solal M; Galacteros F
Hemoglobin; 1986; 10(1):21-31. PubMed ID: 3754242
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and characterization of Hb C/Hb Iowa: a rare but easily misidentified compound heterozygous condition.
Somjee S; Yu LC; Hagar AF; Hempe JM
Hemoglobin; 2004 Feb; 28(1):7-13. PubMed ID: 15008260
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin Evanston: alpha 14(A12) Trp leads to Arg. A variant hemoglobin associated with alpha-thalassemia-2.
Moo-Penn WF; Baine RM; Jue DL; Johnson MH; McGuffey JE; Benson JM
Biochim Biophys Acta; 1983 Sep; 747(1-2):65-70. PubMed ID: 6882779
[TBL] [Abstract][Full Text] [Related]
36. Modification of hemoglobin H disease by sickle trait.
Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
[TBL] [Abstract][Full Text] [Related]
37. Rapid molecular characterization of Hb Queens and Hb Siam: two variants easily misidentified as sickle Hb.
Fucharoen S; Singsanan S; Hama A; Fucharoen G; Sanchaisuriya K
Clin Biochem; 2007 Jan; 40(1-2):137-40. PubMed ID: 17014836
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin S/hemoglobin City of Hope compound heterozygote with a SubSaharan genetic background and severe bone marrow hypoplasia.
Paradisi I; González N; Hernández A; Arias S
Invest Clin; 2010 Sep; 51(3):403-14. PubMed ID: 21302591
[TBL] [Abstract][Full Text] [Related]
39. Strategy for identification by mass spectrometry of a new human hemoglobin variant with two mutations in Cis in the beta-globin chain: Hb S-Clichy [beta6(A3)Glu-->Val; beta8(A5)Lys-->Thr].
Zanella-Cleon I; Préhu C; Joly P; Riou J; Becchi M; Wajcman H; Francina A
Hemoglobin; 2009; 33(3):177-87. PubMed ID: 19657831
[TBL] [Abstract][Full Text] [Related]
40. Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
Tubman VN; Bennett CM; Luo HY; Chui DH; Heeney MM
Pediatr Blood Cancer; 2007 Aug; 49(2):207-10. PubMed ID: 17551985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
